112 related articles for article (PubMed ID: 17257776)
1. Mechanisms of progression of ductal carcinoma in situ of the breast to invasive cancer. A hypothesis.
Cocker R; Oktay MH; Sunkara JL; Koss LG
Med Hypotheses; 2007; 69(1):57-63. PubMed ID: 17257776
[TBL] [Abstract][Full Text] [Related]
2. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity in ductal carcinoma in situ and invasive breast cancer.
Umbricht CB; Sherman ME; Dome J; Carey LA; Marks J; Kim N; Sukumar S
Oncogene; 1999 Jun; 18(22):3407-14. PubMed ID: 10362362
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis and inflammation in ductal carcinoma in situ of the breast.
Lee AH; Happerfield LC; Bobrow LG; Millis RR
J Pathol; 1997 Feb; 181(2):200-6. PubMed ID: 9120726
[TBL] [Abstract][Full Text] [Related]
5. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of ductal carcinoma in-situ of breast and its correlation with the grade of associated invasive component.
Konar K; Chatterjee U; Dutta SK
Indian J Pathol Microbiol; 2001 Jul; 44(3):297-300. PubMed ID: 12024916
[TBL] [Abstract][Full Text] [Related]
7. The impact of large sections on the study of in situ and invasive duct carcinoma of the breast.
Foschini MP; Flamminio F; Miglio R; Calò DG; Cucchi MC; Masetti R; Eusebi V
Hum Pathol; 2007 Dec; 38(12):1736-43. PubMed ID: 17714759
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cells in ductal carcinoma in situ of the breast.
Lee AH; Dublin EA; Bobrow LG
J Pathol; 1999 Feb; 187(3):285-90. PubMed ID: 10398080
[TBL] [Abstract][Full Text] [Related]
9. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
10. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.
Esposito NN; Dabbs DJ; Bhargava R
Am J Clin Pathol; 2009 Feb; 131(2):228-42. PubMed ID: 19141383
[TBL] [Abstract][Full Text] [Related]
11. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.
Iakovlev VV; Arneson NC; Wong V; Wang C; Leung S; Iakovleva G; Warren K; Pintilie M; Done SJ
Clin Cancer Res; 2008 Jul; 14(14):4446-54. PubMed ID: 18628458
[TBL] [Abstract][Full Text] [Related]
12. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
13. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
Subramaniam MM; Chan JY; Soong R; Ito K; Ito Y; Yeoh KG; Salto-Tellez M; Putti TC
Breast Cancer Res Treat; 2009 Jan; 113(1):113-21. PubMed ID: 18256927
[TBL] [Abstract][Full Text] [Related]
14. The natural history of ductal carcinoma in situ of the breast: a review.
Erbas B; Provenzano E; Armes J; Gertig D
Breast Cancer Res Treat; 2006 May; 97(2):135-44. PubMed ID: 16319971
[TBL] [Abstract][Full Text] [Related]
15. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review.
van Deurzen CH; Hobbelink MG; van Hillegersberg R; van Diest PJ
Eur J Cancer; 2007 Apr; 43(6):993-1001. PubMed ID: 17300928
[TBL] [Abstract][Full Text] [Related]
16. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
[TBL] [Abstract][Full Text] [Related]
17. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
[TBL] [Abstract][Full Text] [Related]
18. The molecular journey from ductal carcinoma in situ to invasive breast cancer.
Wiechmann L; Kuerer HM
Cancer; 2008 May; 112(10):2130-42. PubMed ID: 18383519
[TBL] [Abstract][Full Text] [Related]
19. Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis?
Chagpar AB; McMasters KM; Sahoo S; Edwards MJ
Surgery; 2009 Oct; 146(4):561-7; discussion 567-8. PubMed ID: 19789013
[TBL] [Abstract][Full Text] [Related]
20. [Carcinoma in situ of the breast].
Laenkholm AV; Hoffmann J; Rank FE
Ugeskr Laeger; 2007 Sep; 169(37):3087-90. PubMed ID: 17877955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
